Karen Sims - Net Worth and Insider Trading
Karen Sims Net Worth
The estimated net worth of Karen Sims is at least $402,990 dollars as of 2024-12-28. Karen Sims is the Chief Medical Officer of Arbutus Biopharma Corp and owns about 125,542 shares of Arbutus Biopharma Corp (ABUS) stock worth over $402,990. Details can be seen in Karen Sims's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Karen Sims has not made any transactions after 2024-02-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Karen Sims
Karen Sims Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Karen Sims owns 1 companies in total, including Arbutus Biopharma Corp (ABUS) .
Click here to see the complete history of Karen Sims’s form 4 insider trades.
Insider Ownership Summary of Karen Sims
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ABUS | Arbutus Biopharma Corp | 2024-02-02 | Chief Medical Officer |
Karen Sims Latest Holdings Summary
Karen Sims currently owns a total of 1 stock. Karen Sims owns 125,542 shares of Arbutus Biopharma Corp (ABUS) as of February 2, 2024, with a value of $402,990.
Latest Holdings of Karen Sims
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ABUS | Arbutus Biopharma Corp | 2024-02-02 | 125,542 | 3.21 | 402,990 |
Holding Weightings of Karen Sims
Karen Sims Form 4 Trading Tracker
According to the SEC Form 4 filings, Karen Sims has made a total of 1 transactions in Arbutus Biopharma Corp (ABUS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Arbutus Biopharma Corp is the sale of 4,358 shares on February 2, 2024, which brought Karen Sims around $10,067.
Insider Trading History of Karen Sims
- 1
Karen Sims Trading Performance
Karen Sims Ownership Network
Karen Sims Owned Company Details
What does Arbutus Biopharma Corp do?
Who are the key executives at Arbutus Biopharma Corp?
Karen Sims is the Chief Medical Officer of Arbutus Biopharma Corp. Other key executives at Arbutus Biopharma Corp include Chief Financial Officer David C Hastings , Chief Business Officer Michael J. Mcelhaugh , and Chief Scientific Officer Michael J. Sofia .
Arbutus Biopharma Corp (ABUS) Insider Trades Summary
Over the past 18 months, Karen Sims made 1 insider transaction in Arbutus Biopharma Corp (ABUS) with a net sale of 4,358. Other recent insider transactions involving Arbutus Biopharma Corp (ABUS) include a net sale of 10,164 shares made by Michael J. Mcelhaugh , a net sale of 9,982 shares made by Michael J. Sofia , and a net sale of 9,593 shares made by David C Hastings .
In summary, during the past 3 months, insiders sold 0 shares of Arbutus Biopharma Corp (ABUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 42,943 shares of Arbutus Biopharma Corp (ABUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 42,943 shares.
Arbutus Biopharma Corp (ABUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arbutus Biopharma Corp Insider Transactions
Karen Sims Mailing Address
Above is the net worth, insider trading, and ownership report for Karen Sims. You might contact Karen Sims via mailing address: 701 Veterans Circle, Warminster Pa 18974.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
